socalTECH
MAY 20, 2010
per share, after pricing below its initial offering range on Wednesday evening, and had traded as high as $15.26 The firm, which is headed by Zorik Gordon, was venture backed by VantagePoint Venture Partners, Rho Ventures, Galleon Group, European Founders Fund, and others. The firm sold 4,166,667 shares of stock at $13.00
Xconomy
JUNE 10, 2016
Guardant is funding a series of trials around the country in people whose genetic or lifestyle profiles put them at high risk of five types of cancer. As the conference wrapped up, a Morgan Stanley analyst noted that Pfizer the previous week had raised its drug prices nine percent, continuing a regular pattern of price increases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
AUGUST 26, 2016
Mylan bumped up the price of the EpiPen 400 percent, presidential nominee Hillary Clinton responded with a tirade against drug price hikes, and—much like when Clinton railed against drug pricing last year—biotech indexes promptly plummeted more than 3 percent. It was the tweet heard around the biotech world, again.
socalTECH
APRIL 29, 2014
Unfortunately, those providers decided the gold leads were expensive, and decided to use a Chinese vendor which would provide them at half price. How are you funding this project? This is really also funded because of Mike and my other project, the 101 incubator. So imagine, they''d just pfft and kill the guy.
socalTECH
OCTOBER 29, 2015
in a funding round. I grew up in Thousand Oaks, went to USC, and we met each other way back in the 90's. Those loans are very mis-priced, in our opinion. Earlier this week, Manhattan Beach-based PeerStreet (www.peerstreet.com) announced the launch of its online lending marketplace for real estate, plus a $6.1M
Expert insights. Personalized for you.
157 
Let's personalize your content